entertainment -WSS

entertainment

author：hotspot 2025-09-27 21:55:53 - browse：659

WASHINGTON — Plenty of pharmaceutical executives have decried Democrats’ new drug pricing law as detrimental to the industry. But few are willing to say they may be willing to delay treatments for cancer patients if it means making more money.

Genentech CEO Alexander Hardy, in an interview with STAT, explained that in the world that existed prior to the Inflation Reduction Act’s passage last year, drugmakers were incentivized to get drugs on the market as fast as possible, regardless of which disease they would be approved to treat.

Now, he’s arguing that the law’s new Medicare negotiation program could encourage Genentech to slow-walk research on how a drug could treat diseases with smaller populations in favor of making sure diseases with larger patient populations are the first to market. That would mean the company would sell more medicines in the window before Medicare is allowed to negotiate prices, because the clock for when discounts can kick in is based off of when the drug first goes on the market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： What American doctors can learn from their Israeli counterparts

explore

WSS

Listen: Biogen's potential pivot, & Illumina's next chapter

Are infertility treatments 'essential' during the Covid

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

Weighted lottery helped low

Stanford president’s abrupt resignation sparks debate

Humana sues Biden admin over Medicare Advantage audit rule

entertainment

entertainment

hotspot

ChatGPT in medicine: STAT answers readers' burning questions

US jobless claims fall again as labor market continues to flash strength

Moonlake's readout produced a cash windfall. Risks remain

The 10 drugs up first for Medicare price negotiation

Drug repurposing or repositioning? The language matters

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

BioMarin wins approval for gene therapy to treat hemophilia A

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

Guidelines to prevent youth baseball injuries need more muscle

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

hotspot

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

A new ‘biological computer' targets cancer while sparing healthy cells

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

How a Boston hospital is priming medical residents to use GPT

How a Boston hospital is priming medical residents to use GPT

How a Boston hospital is priming medical residents to use GPT

Wikipedia

hotspot

explore

knowledge